Nilai Agregat Aset: Windtree (WINT)

Windtree Therapeutics (WINT) develops cardiology treatments whose scalability relies on patent protection and future production outsourcing. The company is currently restructuring its pipeline, focusing on completing Phase II trials of its shock therapy. The price action of total assets on GURU.Markets is 0.00. However, the business faces a liquidity shortage and serious concerns regarding regulatory approval of its drugs.

Total assets represent the aggregate value of resources and liabilities, where the asset dynamics of Windtree Therapeutics (WINT) based on ROA allow for the assessment of financial stability through a reverse profitability calculation. This indicator reveals the actual scale of the business, which for Windtree Therapeutics is determined by the value of intellectual property and the development of emergency cardiology drugs that form the foundation for future government procurement.